Labcorp Holdings Inc. (FRA:N6B)
Germany · Delayed Price · Currency is EUR 220.00
-4.00 (-1.79%)
At close: Jan 29, 2026
Labcorp Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 13,765 | 13,009 | 12,162 | 11,864 | 13,136 | 13,979 | |
Revenue Growth (YoY) | 8.28% | 6.97% | 2.51% | -9.69% | -6.03% | 20.98% |
Cost of Revenue | 9,850 | 9,385 | 8,797 | 8,155 | 8,144 | 9,026 |
Gross Profit | 3,916 | 3,624 | 3,365 | 3,709 | 4,992 | 4,953 |
Selling, General & Admin | 2,273 | 2,230 | 2,032 | 1,763 | 1,690 | 1,729 |
Amortization of Goodwill & Intangibles | 277.8 | 256.4 | 219.8 | 193.6 | 141.1 | 247.9 |
Operating Expenses | 2,551 | 2,486 | 2,252 | 1,957 | 1,831 | 1,977 |
Operating Income | 1,365 | 1,138 | 1,113 | 1,752 | 3,161 | 2,976 |
Interest Expense | -232.5 | -208.3 | -199.6 | -179.8 | -211.8 | -207.4 |
Interest & Investment Income | 26.7 | 22.3 | 28.8 | 7.5 | 8.8 | 10.3 |
Earnings From Equity Investments | -7.9 | -1.4 | -1.4 | 5.4 | 26.5 | 2.9 |
Currency Exchange Gain (Loss) | -15.3 | -15.3 | - | - | - | - |
Other Non Operating Income (Expenses) | 111.1 | 160.5 | 77.3 | -32.2 | -46.3 | -32.1 |
EBT Excluding Unusual Items | 1,247 | 1,096 | 1,018 | 1,553 | 2,938 | 2,749 |
Merger & Restructuring Charges | -12.9 | -46.4 | -54 | -54.5 | -24 | -40.6 |
Impairment of Goodwill | - | - | -333.6 | - | - | -422.4 |
Gain (Loss) on Sale of Investments | -36.5 | -11.4 | -4.8 | - | 61.8 | - |
Gain (Loss) on Sale of Assets | 1.5 | 6.4 | - | - | - | - |
Asset Writedown | -3.5 | -5.3 | -15.4 | -261.7 | -88.4 | -67.2 |
Other Unusual Items | -94.9 | -79.6 | -41.2 | 0.5 | - | - |
Pretax Income | 1,101 | 959.5 | 568.9 | 1,237 | 2,888 | 2,219 |
Income Tax Expense | 244.3 | 212.4 | 188.5 | 233.9 | 690 | 662.1 |
Earnings From Continuing Operations | 856.4 | 747.1 | 380.4 | 1,004 | 2,198 | 1,557 |
Earnings From Discontinued Operations | - | - | 38.8 | 277.1 | 181.9 | - |
Net Income to Company | 856.4 | 747.1 | 419.2 | 1,281 | 2,380 | 1,557 |
Minority Interest in Earnings | -1.2 | -1.1 | -1.2 | -1.5 | -2.2 | -0.9 |
Net Income | 855.2 | 746 | 418 | 1,279 | 2,377 | 1,556 |
Net Income to Common | 855.2 | 746 | 418 | 1,279 | 2,377 | 1,556 |
Net Income Growth | 96.37% | 78.47% | -67.32% | -46.20% | 52.77% | 88.89% |
Shares Outstanding (Basic) | 83 | 84 | 87 | 91 | 97 | 97 |
Shares Outstanding (Diluted) | 84 | 84 | 88 | 92 | 98 | 98 |
Shares Change (YoY) | -0.85% | -3.65% | -4.37% | -6.05% | -0.51% | -0.61% |
EPS (Basic) | 10.25 | 8.89 | 4.80 | 14.04 | 24.58 | 15.99 |
EPS (Diluted) | 10.19 | 8.84 | 4.77 | 13.97 | 24.39 | 15.88 |
EPS Growth | 98.37% | 85.21% | -65.82% | -42.73% | 53.56% | 90.18% |
Free Cash Flow | 1,381 | 1,096 | 874.1 | 1,417 | 2,597 | 1,754 |
Free Cash Flow Per Share | 16.43 | 12.98 | 9.98 | 15.47 | 26.63 | 17.89 |
Dividend Per Share | 2.880 | 2.880 | 2.880 | 2.160 | - | - |
Dividend Growth | - | - | 33.33% | - | - | - |
Gross Margin | 28.44% | 27.86% | 27.67% | 31.26% | 38.01% | 35.43% |
Operating Margin | 9.92% | 8.75% | 9.15% | 14.77% | 24.06% | 21.29% |
Profit Margin | 6.21% | 5.73% | 3.44% | 10.78% | 18.10% | 11.13% |
Free Cash Flow Margin | 10.03% | 8.42% | 7.19% | 11.95% | 19.77% | 12.54% |
EBITDA | 1,964 | 1,701 | 1,621 | 2,222 | 3,664 | 3,478 |
EBITDA Margin | 14.26% | 13.08% | 13.33% | 18.73% | 27.89% | 24.88% |
D&A For EBITDA | 598.6 | 563.4 | 507.8 | 469.5 | 503.3 | 502.4 |
EBIT | 1,365 | 1,138 | 1,113 | 1,752 | 3,161 | 2,976 |
EBIT Margin | 9.92% | 8.75% | 9.15% | 14.77% | 24.06% | 21.29% |
Effective Tax Rate | 22.20% | 22.14% | 33.13% | 18.90% | 23.89% | 29.84% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.